0R15 8780.0 -1.0593% 0R1E 8527.0 2.6237% 0M69 None None% 0R2V 234.75 9868.1529% 0QYR 1479.0 -3.7109% 0QYP 426.4 -0.6061% 0RUK None None% 0RYA 1496.0 -2.4772% 0RIH 168.8 0.0% 0RIH 169.0 0.1185% 0R1O 208.12 10254.2289% 0R1O None None% 0QFP 10566.6201 109.6552% 0M2Z 267.9939 0.2127% 0VSO 31.38 -11.8663% 0R1I None None% 0QZI 574.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 164.74 0.3166%

small-cap

An Update On One FTSE AIM All-Share Index Listed Stock - INS

Aug 30, 2023 | Team Kalkine
An Update On One FTSE AIM All-Share Index Listed Stock - INS

Instem PLC

Instem PLC (LSE: INS) is an FTSE AIM All-Share index-listed leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection. This Report covers the Investment Highlights, Conclusion, and Recommendation on the stock.

Investment Rationale – Sell at GBX 823.25

  • Resistance near Current levels: INS’s stock price crossed reached the Resistance (R2) stated in the previous report on 20 July 2023, and might witness some sell-off from the current levels. Considering the market conditions and the price action, it is prudent to exit the stock, as the prices might pull back from these levels.
  • Sluggish Profitability Margins: For FY22, the EBITDA margin of the group was 18.4% against the industry median of 25.9% and the operating margin of INS slipped to 9.5% in the same period (FY22) against the industry median of 13.1%. Also, the company reported a lower Net margin of 8.0% in FY22 as compared to the industry median of 14.0%.
  • Declining liquidity ratios: The group’s quick ratio for FY22 was reported at 0.93x, which is lower than the industry median of 1.30x. Further, INS’s current ratio declined to 0.93x during Q3FY22, against the industry median of 1.30x.

Share Price Chart  

Conclusion

Based on the notional gains, macroeconomic challenges, and price action stance, a "SELL" recommendation on Instem PLC (LSE: INS) has been given at the current market price of GBX 823.25 (as of 30 August 2023, 10:50 AM, GMT+1).

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 30 August 2023. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions